- Home
- IDYA vs DJTWW Comparison
IDYA vs DJTWW Comparison
Compare IDYA & DJTWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- DJTWW
- Stock Information
- Founded
- IDYA 2015
- DJTWW 2021
- Country
- IDYA United States
- DJTWW United States
- Employees
- IDYA N/A
- DJTWW 29
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- DJTWW Computer Software: Programming Data Processing
- Sector
- IDYA Health Care
- DJTWW Technology
- Exchange
- IDYA Nasdaq
- DJTWW Nasdaq
- Market Cap
- IDYA 2.3B
- DJTWW 2.5B
- IPO Year
- IDYA 2019
- DJTWW N/A
- Fundamental
- Price
- IDYA $27.16
- DJTWW $8.94
- Analyst Decision
- IDYA Buy
- DJTWW
- Analyst Count
- IDYA 14
- DJTWW 0
- Target Price
- IDYA $49.17
- DJTWW N/A
- AVG Volume (30 Days)
- IDYA 953.6K
- DJTWW 172.0K
- Earning Date
- IDYA 11-03-2025
- DJTWW 04-02-2025
- Dividend Yield
- IDYA N/A
- DJTWW N/A
- EPS Growth
- IDYA N/A
- DJTWW N/A
- EPS
- IDYA N/A
- DJTWW N/A
- Revenue
- IDYA $7,000,000.00
- DJTWW $3,369,800.00
- Revenue This Year
- IDYA $62.30
- DJTWW N/A
- Revenue Next Year
- IDYA $285.58
- DJTWW N/A
- P/E Ratio
- IDYA N/A
- DJTWW N/A
- Revenue Growth
- IDYA N/A
- DJTWW N/A
- 52 Week Low
- IDYA $13.45
- DJTWW $6.53
- 52 Week High
- IDYA $39.30
- DJTWW $44.83
- Technical
- Relative Strength Index (RSI)
- IDYA 70.30
- DJTWW N/A
- Support Level
- IDYA $24.04
- DJTWW N/A
- Resistance Level
- IDYA $25.39
- DJTWW N/A
- Average True Range (ATR)
- IDYA 1.05
- DJTWW 0.01
- MACD
- IDYA 0.16
- DJTWW -0.74
- Stochastic Oscillator
- IDYA 99.45
- DJTWW 0.86
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.